1993
DOI: 10.1016/s0002-9610(05)80968-7
|View full text |Cite
|
Sign up to set email alerts
|

Clinical utilization and complications of sural nerve biopsy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
48
1
5

Year Published

2001
2001
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 96 publications
(55 citation statements)
references
References 9 publications
1
48
1
5
Order By: Relevance
“…Indeed, given the 20% prevalence of distal symmetric polyneuropathy among reported patients with NSVN, nerve biopsy should be considered in all patients with progressive axonal neuropathies, irrespective of symmetry. That said, among patients with an idiopathic, chronic, symmetric polyneuropathy, nerve biopsy yields a diagnosis of definite vasculitis in only 3% [109][110][111] , much lower than the 20% yield among patients with a clinical phenotype that raises suspicion of vasculitis [112][113][114] . This low yield must, therefore, be weighed against the risks of biopsy.…”
Section: Brighton Collaboration Case Definition Of Vasculitic Neuropamentioning
confidence: 99%
“…Indeed, given the 20% prevalence of distal symmetric polyneuropathy among reported patients with NSVN, nerve biopsy should be considered in all patients with progressive axonal neuropathies, irrespective of symmetry. That said, among patients with an idiopathic, chronic, symmetric polyneuropathy, nerve biopsy yields a diagnosis of definite vasculitis in only 3% [109][110][111] , much lower than the 20% yield among patients with a clinical phenotype that raises suspicion of vasculitis [112][113][114] . This low yield must, therefore, be weighed against the risks of biopsy.…”
Section: Brighton Collaboration Case Definition Of Vasculitic Neuropamentioning
confidence: 99%
“…Most of the articles discussed the nerve biopsy findings in specific diseases, the clinical suspicion of which had prompted the biopsy. [23][24][25][26][27][28][29][30][31][32][33][34] No article provided guidance regarding when to perform a nerve biopsy in the evaluation of DSP.…”
Section: Analysis Of Evidencementioning
confidence: 99%
“…However, disadvantages include prolonged operative times, higher facility costs, and donor site morbidity which may include pain, scarring, neuroma formation, and sensory loss. (5,6,7,8) Autograft alternatives include allografts and artificial nerve conduits, which eliminate donor site morbidity. Several clinical studies have documented the effectiveness of nerve conduits for short gaps (9); however, the clinical value of nerve conduits to bridge larger gaps remains unclear.…”
Section: Introductionmentioning
confidence: 99%